九强生物 (300406.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(九强生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,237,396,355.82821,722,324.81393,894,885.381,741,626,675.371,233,685,019.60816,327,794.28373,395,954.06
 营业收入(元) 1,237,396,355.82821,722,324.81393,894,885.381,741,626,675.371,233,685,019.60816,327,794.28373,395,954.06
二、营业总成本(元) 793,399,425.93518,454,199.71252,157,863.841,152,367,616.41808,875,161.23541,125,105.91248,450,721.02
 营业成本(元) 274,578,957.58186,299,645.9891,143,372.70441,259,980.15300,976,698.29207,517,915.5094,809,175.25
 研发费用(元) 129,511,221.9886,944,037.4542,889,988.58162,898,782.94109,912,038.8374,814,506.2436,221,121.73
 营业税金及附加(元) 11,938,565.267,278,214.323,668,591.4314,968,576.3010,968,070.127,093,875.763,629,242.20
 销售费用(元) 240,932,669.56147,674,341.5169,720,757.44364,053,463.81270,530,981.61174,249,009.7976,099,678.26
 管理费用(元) 105,307,615.9569,914,142.3334,075,533.29126,984,292.2981,487,866.5054,102,210.1925,545,106.30
 财务费用(元) 31,130,395.6020,343,818.1210,659,620.4042,202,520.9234,999,505.8823,347,588.4312,146,397.28
  其中:利息费用(元) 35,441,089.7323,380,926.3811,796,810.8046,992,080.5735,187,662.4323,512,997.2611,584,723.81
  其中:利息收入(元) 4,752,693.993,414,971.121,563,513.655,187,911.351,082,609.08794,996.53543,089.59
三、其他经营收益
 加:投资收益(元) 1,725,900.911,398,418.931,115,166.9220,763,691.846,674,501.736,351,121.172,247,656.12
 资产处置收益(元) -2,201,612.67-1,247,038.46-290,627.64-3,495,156.98-2,441,385.03-1,770,710.38439,404.14
 资产减值损失(元) ----3,746,940.60---
 信用减值损失(元) -6,781,439.51-6,782,017.9190,000.00-26,744,200.79-11,429,987.38-11,562,843.38-
 其他收益(元) 6,937,950.176,007,446.001,728,678.6317,839,934.794,129,987.903,550,318.811,778,112.57
四、营业利润(元) 443,677,728.79302,644,933.66144,380,239.45593,876,387.22421,742,975.59271,770,574.59129,410,405.87
 加:营业外收入(元) 68,893.2722,857.2815,714.3081,447.96106,353.3069,824.4854,116.08
 减:营业外支出(元) 2,213,723.092,092,835.031,988,002.82403,271.12189,020.79164,716.03114,220.93
五、利润总额(元) 441,532,898.97300,574,955.91142,407,950.93593,554,564.06421,660,308.10271,675,683.04129,350,301.02
 减:所得税费用(元) 69,130,619.9750,987,663.6522,188,466.8971,484,904.1953,555,705.8632,342,111.3319,406,635.79
六、净利润(元) 372,402,279.00249,587,292.26120,219,484.04522,069,659.87368,104,602.24239,333,571.71109,943,665.23
(一)按经营持续性分类
  持续经营净利润(元) 372,402,279.00249,587,292.26120,219,484.04522,069,659.87368,104,602.24239,333,571.71109,943,665.23
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 373,384,271.63250,373,606.97120,648,449.77523,742,821.32371,317,794.78241,568,564.76111,021,507.44
  少数股东损益(元) -981,992.63-786,314.71-428,965.73-1,673,161.45-3,213,192.54-2,234,993.05-1,077,842.21
 扣除非经常性损益后的净利润(元) 371,187,295.72248,090,493.65121,105,155.14510,697,738.26368,846,446.93239,029,039.38109,188,936.22
七、每股收益
 一、基本每股收益(元) 0.630.430.210.900.630.410.19
 二、稀释每股收益(元) 0.630.430.210.880.630.410.19
八、其他综合收益(元) -163,841.94110,421.3637,868.49218,516.48406,951.97504,177.12-243,119.00
 归属于母公司股东的其他综合收益(元) -135,197.2785,240.6427,198.35160,849.98305,010.50377,880.75-182,217.69
 归属于少数股东的其他综合收益(元) -28,644.6725,180.7210,670.1457,666.50101,941.47126,296.37-60,901.31
九、综合收益总额(元) 372,238,437.06249,697,713.62120,257,352.53522,288,176.35368,511,554.21239,837,748.83109,700,546.23
 归属于母公司所有者的综合收益总额(元) 373,249,074.36250,458,847.61120,675,648.12523,903,671.30371,622,805.28241,946,445.51110,839,289.75
 归属于少数股东的综合收益总额(元) -1,010,637.30-761,133.99-418,295.59-1,615,494.95-3,111,251.07-2,108,696.68-1,138,743.52
公告日期 2024-10-292024-08-232024-04-292024-03-302023-10-252023-08-102023-04-28
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院